Item 9 Labs Corp (INLB)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Item 9 Labs Cash from Investing (Quarterly): -0.0628M for June 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -0.0628M |
| March 31, 2023 | 0.0015M |
| December 31, 2022 | -0.0068M |
| September 30, 2022 | -1.391M |
| June 30, 2022 | 0.243M |
| March 31, 2022 | -2.574M |
| December 31, 2021 | -1.439M |
| September 30, 2021 | -0.066M |
| June 30, 2021 | -1.524M |
| March 31, 2021 | -1.137M |
| December 31, 2020 | -1.191M |
| September 30, 2020 | 0.0523M |
| June 30, 2020 | -0.0213M |
| March 31, 2020 | -0.7614M |
| December 31, 2019 | -0.1565M |
| September 30, 2019 | -1.260M |
| June 30, 2019 | -4.101M |
| March 31, 2019 | -0.9764M |
| December 31, 2018 | -1.505M |
| September 30, 2018 | -0.2182M |
| June 30, 2018 | -0.1111M |
| March 31, 2018 | -0.0461M |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 |
| Date | Value |
|---|---|
| March 31, 2017 | 0.00 |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | -0.0067M |
| September 30, 2014 | -0.016M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | -0.0355M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | -0.04M |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.0564M |
| June 30, 2011 | 0.00 |
| March 31, 2011 | -0.0564M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-4.101M
Minimum
Jun 2019
0.243M
Maximum
Jun 2022
-0.9056M
Average
-0.7614M
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
| Humanigen Inc | -- |
| Cantabio Pharmaceuticals Inc | -- |
| Affymax Inc | -- |
| RVL Pharmaceuticals PLC | -0.959M |
| Scopus BioPharma Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.1501M |
| Cash from Financing (Quarterly) | -0.005M |
| Free Cash Flow | -2.597M |
| Free Cash Flow Per Share (Quarterly) | 0.0009 |
| Free Cash Flow to Equity (Quarterly) | -0.8776M |
| Free Cash Flow to Firm (Quarterly) | 3.037M |